Talenom (TNOM) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Profitability improved as planned, driven by efficiency measures in Finland and higher business volumes in Spain, despite slower growth due to reduced acquisition activity and economic downturn in the Nordics.
Acquisition pace slowed significantly, with focus shifting to organic growth, operational efficiency, and building capabilities for future growth, especially leveraging digitalization and regulatory changes.
Net sales grew 6.7% year-over-year to EUR 68.0 million in H1 2024, with EBITDA up 14.6% to EUR 19.7 million and operating profit up 17.3% to EUR 8.4 million.
Growth was mainly driven by acquisitions in Spain, while economic downturns in Finland and Sweden slowed organic growth; new customer acquisition offset some negative impacts.
Over 90% of net sales are recurring, providing a stable foundation for long-term development.
Financial highlights
Group net sales for January–June 2024 were EUR 68.0 million, up 6.7% year-over-year; EBITDA was EUR 19.7 million, up 14.6%, with a margin of 29.0%.
Q2 2024 net sales were EUR 33.9 million (+4.5% y/y); EBITDA EUR 10.3 million (+15.7% y/y, 30.3% margin); EBIT EUR 4.5 million (+22.8% y/y, 13.3% margin).
Operating profit margin for H1 2024 was 12.3%, up from 11.2% in H1 2023.
Cash flow from operations increased 21.6% to EUR 18.2 million; liquid assets at period end were EUR 12.3 million (+14.1% y/y).
Investments in acquisitions dropped 80.4% to EUR 2.7 million compared to the same period last year.
Outlook and guidance
2024 guidance unchanged: net sales expected at EUR 130–140 million, EBITDA EUR 34–40 million, and operating profit EUR 14–17 million.
Growth in the accounting services market is expected to slow in the Nordics but continue elsewhere; demand remains stable, and industry consolidation is anticipated.
Fewer acquisitions expected, focusing on strategic targets; software roll-out in Sweden to weigh on 2024 profitability but expected to benefit future years.
Mid-term goal is for two-thirds of growth to come from organic sources and one-third from acquisitions, targeting over 30% total growth.
Organic growth rate of up to 20% per year is considered achievable in a normal environment, with plans to reach this by 2026.
Latest events from Talenom
- 2026 guidance set at €110–120M net sales and €18–22M EBITDA after Easor demerger.TNOM
Strategy update27 Mar 2026 - Demerger completed; modest sales growth in 2025, with Spain leading and 2026 outlook stable.TNOM
Q4 202511 Mar 2026 - Strategic demerger completed; modest growth, profitability pressured, 2026 outlook positive.TNOM
Q4 202511 Mar 2026 - Profitability surged despite recession, as strategy shifts to core accounting and software focus.TNOM
Q3 202417 Jan 2026 - Net sales and EBITDA rose, driven by Spain, as focus shifted to core software and accounting.TNOM
Q4 20249 Jan 2026 - Profitability improved and Software business separation completed, led by Finnish growth.TNOM
Q1 202528 Nov 2025 - Q2 and H1 2025 saw moderate growth, strong software momentum, and stable guidance.TNOM
Q2 202516 Nov 2025 - Q3 2025 saw 2.4% net sales growth, 45% cash flow gain, and Easor's separation review advanced.TNOM
Q3 202520 Oct 2025 - H1 2025 revenue rose 3.9% to €70.7 million, with solid profitability and stable outlook.TNOM
Q2 202518 Jul 2025